4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-16-034194
Director sold 42,550 shares at $11.71 ($498,078)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Canaan IX L.P. Director | 2016-11-22 | Sale | −42,550 | $11.71 | $498,078 | 3,704,926 | I |
| Open-market sales · 42,550 sh · avg $11.71 · $498,078 | |||||||
Loading xslF345X03/doc4.xml…